In a recent video interview with Applied Clinical Trials, Claire Riches, VP of clinical solutions at Citeline, discussed how AI is transforming the way sponsors approach trial des ...

Community engagement is a powerful tool but its impact depends on how it is done. When it begins early, is sustained over time, and is built through organizations and individuals communities already ...

The new effort combines adaptive platform trial design, AI-enabled site activation, nationwide data infrastructure, and patient data contribution tools to reduce timelines, costs, and patient burden ...

Autonomous capability can expand via new tools, memory, prompts, and delegation despite unchanged models, necessitating ...

In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated ...

In today's ACT Brief, we examine how data drives honest enrollment assumptions, why RWE infrastructure lags ambition, and the ...

AI and digital transformation leader with experience across clinical trials, enterprise technology, product delivery, and regulated transformation. He focuses ...

RWE is finding a role earlier in drug development than ever before, but the data quality, integration, and organizational ...

In this video interview, Claire Riches, VP of clinical solutions at Citeline, explains why combining analog trial performance data with real-world patient data and site-level recruitment history gives ...

In this video interview, Claire Riches, VP of clinical solutions at Citeline, explains why combining analog trial performance ...

In today's ACT Brief, we examine what AI simulations surface in trial design, how RBQM delivers measurable financial returns, ...